Clinical Trials
All Clinical Trials - Page 61 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01278290Phase 3Completed
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Gonadorelin
- NCT01784965Phase 3Completed
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
Liraglutide
- NCT01036841Phase 4Completed
Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
Desmopressin
- NCT01031966Phase 2Completed
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
Thymosin-Alpha-1
- NCT01530607Phase 3Completed
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Gonadorelin
- NCT00943501Phase 1Completed
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide
- NCT01254123Phase 3Unknown
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
Exenatide
- NCT01011556Phase 2Completed
A Study for the Transdermal Application of Teriparatide
Teriparatide
- NCT01028924Phase 1Completed
Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers
Teduglutide
- NCT01003873N/ACompleted
Gastric Bypass and Peripheral Activity of the Endocannabinoid System
Ghrp-6
- NCT00949962Phase 3Terminated
Post-operative or Early Salvage XRT and ADT for High Risk PCa
Gonadorelin
- NCT00993720Phase 2/Phase 3Completed
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Liraglutide
- NCT00993304Phase 1Completed
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
Liraglutide
- NCT01001104Phase 2Completed
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
Dulaglutide
- NCT01003184Phase 3Completed
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Exenatide
- NCT00975286Phase 3Completed
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Lixisenatide
- NCT02305069N/ACompleted
Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle
Octreotide
- NCT01076803Phase 2Completed
Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients
Lanreotide
- NCT01028768Phase 1Completed
Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function
Teduglutide
- NCT01534117N/ACompleted
Platelet Function Analysis in Head Trauma: ASA/Plavix
Desmopressin
- NCT00930644Phase 3Completed
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Teduglutide
- NCT00978393Phase 1Completed
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
Liraglutide
- NCT00979745Phase 3Completed
Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Afamelanotide
- NCT03634137Phase 1Completed
Implant Pharmacokinetic and Pharmacodynamic Study
Afamelanotide
- NCT00983021Phase 1Completed
Safety and Tolerability of NN9068 in Healthy Male Volunteers
Liraglutide
- NCT01046721N/ACompleted
Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
Exenatide
- NCT01580514Phase 4Completed
Myocardial Protection of Exenatide in AMI
Exenatide
- NCT00960661Phase 3Completed
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Exenatide
- NCT01013506Phase 2Withdrawn
Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer
Gonadorelin
- NCT00943917Phase 2Completed
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00964262Phase 1Completed
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
Exenatide
- NCT01269047Phase 4Completed
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Exenatide
- NCT00790699N/ATerminated
Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
Pramlintide
- NCT01165944Phase 1/Phase 2Withdrawn
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus
Pramlintide
- NCT00976937Phase 3Completed
24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
Lixisenatide
- NCT00981682Phase 3Completed
Long Term Safety Assessment of SER120 in Patients With Nocturia
Desmopressin
- NCT00935558Phase 2Withdrawn
Dendritic Cell Based Therapy for Breast Cancer Patients
Thymosin-Alpha-1
- NCT00799435Phase 4Terminated
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
Exenatide
- NCT00950677Phase 4Completed
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Exenatide
- NCT00917267Phase 3Completed
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
Exenatide
- NCT00935532Phase 3Completed
Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
Exenatide
- NCT00942851Phase 1/Phase 2Completed
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Argireline
- NCT00927186Phase 4Completed
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
Teriparatide
- NCT00884715Phase 1/Phase 2Terminated
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome
Octreotide
- NCT00891371Phase 2/Phase 3Completed
Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea
Lanreotide
- NCT00938717Phase 3Completed
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide
- NCT00948818Phase 3Completed
Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
Linaclotide
- NCT00914823Phase 1Completed
Kisspeptin Administration in the Adult
Kisspeptin
- NCT00896532Phase 2Completed
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Teriparatide
- NCT00933361Phase 1/Phase 2Completed
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Ghrp-6